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Abstract
Background: Exosomes are defined as extracellular membrane vesicles, 30–150 nm in diameter, derived from all
types of cells. They originate via endocytosis and then they are released through exocytosis to the extracellular
space, being found in various biological fluids as well as in cell culture medium. In the last few years, exosomes
have gained considerable scientific interest due to their potential use as biomarkers, especially in the field of cancer
research. This report describes a method to isolate, quantify and identify serum- and cell culture-derived exosomes
from dog samples, using small volumes (100 μL and 1 mL, respectively).
Results: Quantification and sizing of exosomes contained in serum and cell culture samples were assessed by
utilizing nanoparticle tracking analysis, transmission electron microscopy and immunoelectron microscopy.
Detected particles showed the normal size (30–150 nm) and morphology described for exosomes, as well as
presence of the transmembrane protein CD63 known as exosomal marker.
Conclusions: Based on a validated rapid isolation procedure of nanoparticles from small volumes of different types
of dog samples, a characterization and exploration of intact exosomes, as well as facilitation for their analysis in
downstream applications was introduced.
Keywords: Exosomes, Serum, Cell culture medium, Dog, Transmission electron microscopy, Nanoparticle tracking
analysis, Biomarkers
Background
Exosomes are extracellular nano-sized membrane vesicles,
reported as 30–150 nm in diameter, derived from all types
of cells and released into practically all biological fluids
such as blood, urine, cerebrospinal fluid, milk, sputum,
saliva, seminal fluid, as well as into cell culture medium
[1, 2]. These vesicles originate via endocytosis, initially
forming endosomes and followed by invagination of the
endosomal membrane to create multivesicular bodies
(MVBs). Afterwards through exocytosis, the content of
the MVBs is released as exosomes to the extracellular
space once merging with the plasma membrane [3, 4].
The exosomal membrane consists mostly of lipids and
proteins, while the luminal cargo is mainly represented by
proteins and nucleic acids, including mRNAs, microRNAs,
other non-coding RNAs and DNA [5–7]. Exosomes have
been proven to possess several functions, for instance,
intercellular communication, genetic exchange and antigen
presentation, allowing cells to transport their cargo in a
short and long distance manner and subsequently having a
significant effect at a cellular and biological level [6, 7].
Since exosomes are of endosomal origin, they contain a dis-
tinct set of proteins involved in membrane transport and
fusion (e.g. Rab GTPases, annexins, flotillin), biogenesis of
MVBs (Alix, TSG101), major histocompatibility complex
class I and II, in processes requiring heat shock proteins
(hsc70 and 90), integrins and tetraspanins (e.g. CD63, CD9,
CD81 and CD82) [6, 8, 9]. Even though some of these
proteins are used as exosome markers, exosomal protein
composition might differ based on the origin of the cells or
tissue [7, 10].
Analyses of cargo proteins and nucleic acids present in
exosomes show significant potential to be employed as exo-
somal biomarkers. Taking this into consideration, together
with the ability to easily isolate exosomes from body fluids
(liquid biopsy), these vesicles may deliver an additional
valuable non-invasive biomarker for predisposition, prog-
nosis and treatment monitoring in the cancer research field
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[7, 11]. Furthermore, when understanding endogenous
transmission of distinct macromolecules between tissues
via exosomes, a (dys) functional cell-cell communication
could be focused (diagnostic tool) and subsequently modi-
fied (therapeutic tool).
In this report we describe a method to isolate and identify
serum- and cell culture-derived exosomes from dog sam-
ples. This study provides comprehensive techniques such
as transmission electron microscopy, nanoparticle tracking
analysis and immunodetection to identify and characterize
exosomes, allowing them to be quantified and sized, as well




Samples (n = 10) were gathered from 5 female and 5 male
dogs of different ages (between 1 and 7 years old),
non-cancer (n = 6) and cancer patients (n = 4), presented
at the Small Animal Clinic, Department of Veterinary
Medicine at the Freie Universität Berlin. Blood samples
were collected in tubes without anticoagulant and left at
room temperature to allow clotting for 30 min to 2 h. The
main portion of the serum was used for the original diag-
nostic laboratory analyses, while the remaining amount
was employed for this study. The protocol to separate and
store serum was based on a published technical note from
QIAGEN (miRNeasy Serum/Plasma Handbook 02/2012).
Briefly, tubes were first centrifuged at 2000 x g for 10 min
at 4 °C to separate residual cellular components of the
blood. The supernatant was then placed in another tube
and centrifuged at 16,000 x g for 10 min at 4 °C to separ-
ate any left cellular debris. Afterwards, the purified serum
was taken and stored in − 80 °C until exosome isolation.
Cell cultures
C2 cell line
C2 cells, a canine mast cell tumour cell line, were
kindly provided in August 2016 by Dr. Patrice
Dubreuil (Centre de Recherche en Cancérologie de
Marseille, Inserm U1068, Marseille, France), after pre-
vious consent of the cell line originator, Dr. Warren
Gold (University of California San Francisco, School
of Medicine, California, USA) [12]. Cells were
cultured in RPMI 1640 medium, supplemented with
10% foetal bovine serum (FBS) superior, 100 U/mL
penicillin/streptomycin (all from Biochrom, Berlin,
Germany), 1 mM/mL sodium pyruvate and 2 mM/mL
glutamine (both from Sigma, MO, USA), and
incubated in a 5% CO2 atmosphere at 37 °C. Special
culture conditions were applied before exosomes were
harvested (see exosome isolation paragraph).
Primary canine fibroblasts culture
Fibroblasts (FBs) were obtained from a portion of
healthy skin of a female Golden Retriever, within 20 min
after the animal was euthanized at the Small Animal
Clinic, Department of Veterinary Medicine at the Freie
Universität Berlin. The skin was collected in sterile Dul-
becco’s phosphate buffer saline (DPBS) (Sigma, MO,
USA) and then placed in a Petri dish. Dermis was sepa-
rated from epidermis using sterile forceps and scalpels.
The dermis was cut in small pieces (1 × 3 mm approx.)
and washed in DPBS, supplemented with 100 U/mL
penicillin/streptomycin and 250 μg/mL amphotericin B
(Biochrom, Berlin, Germany). Then, a 5 min centrifuga-
tion at 300 x g was performed and the supernatant was
discarded. The sediment, representing the FBs, was re-
suspended in an enzymatic digestion medium containing
0.15% collagenase I (Biochrom, Berlin, Germany), RPMI
1640 medium, supplemented with antibiotic and fungi-
cide as described above, and 1% 70 mM CaCl2 (Merck,
Darmstadt, Germany). The sample was transferred into
a Petri dish and incubated at 37 °C for 2 h under con-
stant agitation, then placed into a sterile 50 mL tube and
centrifuged 5 min at 300 x g, the supernatant was dis-
carded. The pellet was washed twice in warm (37 °C)
RPMI 1640 medium, supplemented with 20% FBS,
100 U/mL penicillin/streptomycin, 250 μg/mL ampho-
tericin B, 1 mM/mL sodium pyruvate and 2 mM/mL
glutamine, and centrifuged 5 min at 300 x g. Lastly, the
resulting pellet was seeded in a T25 flask in 7 ml of the
same medium used for the last two washing steps and
incubated in a 5% CO2 atmosphere at 37 °C. The first
passage was performed 10 days after seeding and passage
number 5 was used for the exosome isolation. Special
culture conditions were applied before exosomes were
harvested (see exosome isolation paragraph).
Exosome isolation
Serum samples
Exosome isolation from serum samples was accomplished
using a commercial kit (Total Exosome Isolation Reagent –
from serum; Invitrogen, Vilnius, Lithuania) following the
manufacturer’s protocol. Briefly, purified serum was passed
through a 0.22 μm pore PVDF filter (Rotilabo, Karlsruhe,
Germany). After that, 100 μL of filtered serum was mixed
with 20 μL of reagent and incubated at 4 °C for 30 min.
Then, samples were centrifuged at 16,000 x g for 10 min at
room temperature and the supernatant was discarded. The
pellet containing exosomes was resuspended in 20 to 50 μL
of DPBS, depending on the downstream applications.
Cell culture samples
In cell culture medium from the C2 cell line and from
the primary FBs culture, exosome isolation was per-
formed utilizing a commercial kit (Total Exosome
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Isolation Reagent – from cell culture media; Invitrogen,
Vilnius, Lithuania), although some modifications to the
manufacturer’s protocol were applied. For this purpose,
prior to culturing cells for exosome isolation, 50–80%
confluent C2 cells and primary FBs were washed twice
in DPBS and further cultured in an exosome-free
medium as described above, except for using
exosome-depleted FBS (Gibco, USA). Briefly, cell culture
medium was harvested after 48 and 72 h of incubation
with exosome-depleted medium and centrifuged at room
temperature; first, 5 min at 300 x g to remove floating
cells and a subsequent 30 min 3000 x g centrifugation to
eliminate cellular debris. Afterwards, the purified
medium was passed through a 0.22 μm pore PVDF filter
and then 1 mL of filtered medium was mixed with the
volume of reagent indicated by the manufacturer. The
mixture was incubated at 4 °C overnight and finally cen-
trifuged at 4 °C at 11,000 x g for 60 min. The pellet con-
taining exosomes was re-suspended in 20 to 50 μL of
DPBS, depending on the downstream applications.
Transmission electron microscopy (TEM)
To identify exosomes and investigate their ultrastructural
morphology, a Zeiss EM 109 transmission electron micro-
scope (Carl Zeiss, Oberkochen, Germany) operating at
80 kV was utilized, following the protocol developed by
Théry et al. (2006) [13], with some modifications.
Native exosomes
For analysis of native exosomes, PBS-suspensions contain-
ing unfixed exosomes were differentially diluted in filtered
PBS (0.22 μm pore PVDF filter). For serum-derived exo-
somes; undiluted suspension and 1:100, 1:1000 and 1:2000
dilutions were used, while for culture-derived exosomes;
undiluted suspension and 1:50, 1:100 and 1:200 dilutions
were applied. Formvar-carbon-coated 100 mesh nickel
grids (Plano, Wetzlar, Germany) were laid on a 5 μL drop
of the exosome-suspension and incubated 20 min at room
temperature for adhesion (coated side of the grid facing
the suspension), then washed 3 times for 3 min in filtered
PBS. Next, grids were placed 2 times on drops of 50 mM
glycine/PBS for 3 min and then transferred to a drop of
0.5% bovine serum albumin (BSA)/PBS blocking solution
for 10 min. For contrasting the exosomes, grids were laid
on 2% uranyl acetate drops for 6 min, followed by 2
washes with distilled water. Grids were allowed to dry
overnight.
Immuno-gold labelled exosomes
For examination of immuno-gold labelled unfixed exo-
somes, anti-CD63 (ABIN1440014, antibodies-online), a
goat polyclonal multi-species primary antibody, and a sec-
ondary antibody anti-goat IgG (whole molecule) labelled
with 10 nm gold (Sigma, MO, USA) were used. The first
part of the protocol was identical to the procedure for
analysis of native exosomes up to placing the grids on
drops of 0.5% BSA/PBS blocking solution for 10 min. This
was followed by an incubation step for 2 h at room
temperature with the primary antibody anti-CD63 (dilu-
tion 1:50 in 0.5% BSA/PBS). Afterwards, grids were
washed 5 times for 3 min in drops of 0.5% BSA/PBS and
an additional incubation with the secondary antibody
anti-goat IgG-10 nm gold (dilution 1:50 in 0.5% BSA/PBS)
was performed for 1 h at room temperature. Grids were
washed again 5 times for 3 min in 0.5% BSA/PBS drops,
and then laid on 2% uranyl acetate drops for 6 min for
contrasting, followed by 2 washes in distilled water. Grids
were allowed to dry overnight.
Nanoparticle tracking analysis (NTA)
Quantification and size determination of dog exosomes
purified from serum and cell culture medium was
assessed by using the NanoSight NS500 instrument
(Malvern, Worcestershire, UK). The NTA 3.0 (build
0064) software visualizes and analyses nanoparticles in
real time by associating Brownian motion with particle
size. Fresh serum- and cell culture-derived exosomes
samples were processed in duplicate and diluted in fil-
tered PBS (0.22 μm pore PVDF filter) until reaching a
concentration between 10 and 100 particles per image
(optimal ~ 50 particles per image) before examination
with the NTA system [14]. The instrument was set up to
operate at 25 °C, three videos, 30 s each, were recorded
for each specimen and outcomes were analysed with the
NTA software.
Statistical analysis
The data analysis was performed using the software
Microsoft Excel 2010 (Microsoft, Redmond, WA, USA),
through one-way analysis of variance (ANOVA) and
Bonferroni corrected post-hoc Student’s t-tests. P value
< 0.05 was considered as significant.
Results
A rapid protocol was validated to isolate nanoparticles
from dog samples suitable to further detect size, quantity
and evaluate selected protein expression.
Size and quantification of exosomes by NTA
A suitable real-time visualization and analysis of exosomes
present in fluid samples could be easily performed by the
NTA system, both in blood serum (Table 1, Fig. 1a) and in
culture media (Table 2, Fig. 1b and c).
Serum samples
100 μL of canine serum was employed to isolate
serum-derived exosomes from 6 non-cancer and 4 can-
cer dog patients. Most of the observed nanoparticles
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were found to be 30 to 150 nm in diameter (Table 1,
Fig. 1a), i.e. the normal size described for exosomes [1, 2],
however few particles showed a larger size. The mean size
range for serum-derived exosomes observed was between
71.3 +/− 3.1 and 113.9 +/− 9.0 nm. In terms of exosome
concentration, in non-cancer patients nanoparticle
concentration (xE10/mL) was between 107.4 +/− 6.8 and
403.2 +/− 25.8, while in cancer patients the lowest and the
highest concentrations (xE10/mL) were 225.6 +/− 10.4
and 500.4 +/− 76.4, respectively. Nevertheless, no signifi-
cant difference (P > 0.05) between non-cancer and cancer
samples could be calculated, although a large variation
within individual samples was detected.
Cell culture medium samples
Exosomes could be isolated from 1 mL of culture medium
obtained from cultured C2 cells and primary FBs, after 48
and 72 h of incubation under exosome-depleted media
conditions. Likewise in the analysis of dog serum samples,
the commercial kit was found suitable for isolating exo-
somes derived from dog cell cultures. The majority of the
nanoparticles exhibited the normal size described for exo-
somes, 30 to 150 nm in diameter (Table 2, Fig. 1b and c)
[1, 2], while a small number was found to be in the 150–
300 nm range. The mean size range for culture-derived
exosomes observed in both types of cultures and both
time-points was between 110.3 +/− 5.0 and 129.0 +/−
7.4 nm. In terms of nanoparticle quantification, after 48
and 72 h C2 cells cultures showed a significant (P < 0.05)
2–3-fold higher exosome concentration compared to pri-
mary FBs cultures but no difference (P > 0.05) between in-
cubation times (48 vs. 72 h) was observed in either group.
Negative controls
To screen for potentially contaminating particles, sam-
ples from all solutions used (PBS, RPMI 1640 medium,
RPMI 1640 + exosome isolation kit, and complete cul-
ture medium + exosome isolation kit) were analysed as
negative controls. The number of particles detected in
these fluids was low and did not affect the total concen-
tration of exosomes per mL counted by the NTA system.
Therefore, exogenous contamination interacting with a
Table 1 Exosome concentration and size distribution
Sample ID Exosome concentration (xE10/mL) Particle size mean (nm) Type of sample
S1 403.2 +/− 25.8 71.3 +/− 3.1 Non-cancer
S2 107.4 +/− 6.8 90.5 +/− 14.5 Non-cancer
S3 322.8 +/− 24.0 89.5 +/− 1.4 Non-cancer
S10 198.0 +/− 19.9 89.9 +/− 13.2 Non-cancer
SHB 374.4 +/− 21.8 112.5 +/− 12.8 Non-cancer
SNT 219.6 +/− 17.3 111.3 +/− 10.7 Non-cancer
S8 397.2 +/− 18.6 113.9 +/− 9.0 Splenic mast cell tumour
SP 225.6 +/− 10.4 99.0 +/− 8.4 Prostatic carcinoma
S15 500.4 +/− 76.4 84.7 +/− 1.5 Perianal adenoma
SVT 277.2 +/− 11.3 84.5 +/− 0.6 Vaginal leiomyosarcoma
Serum-derived exosomes from non-cancer and cancer dog patients (mean +/− standard error)
Fig. 1 Nano track analysis size distribution of exosomes isolated from samples of canine origin. a blood serum-derived exosomes, b C2 cell line
culture-derived exosomes and (c) primary fibroblasts culture-derived exosomes. Red error bars indicate +/− standard error of the mean
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valid characterization of canine exosomes can be ex-
cluded as a factor in our system (Table 3).
Exosome morphology by TEM
General morphology and ultrastructure of serum- and
culture-derived exosomes of canine origin was assessed
by using TEM technology, allowing visualization of the
characteristic central depression or “cup shape” of exo-
somes [15, 16], either single (Fig. 2a and b) or aggregated
(Fig. 2c and d). All samples revealed single and aggre-
gated nanoparticles; non-diluted samples showed a
higher number of exosome aggregates, whereas samples
diluted 1:2000 displayed more individual exosomes, yet
it was more difficult to localize them on the grids.
Morphology and size of the depicted nanoparticles cor-
respond to their exosomal origin, as described in several
studies performed in samples of human fluids and cell
culture origin [1, 13–15].
Protein expression by immunoelectron microscopy
Results presented in Fig. 3 revealed the presence of the
transmembrane protein CD63 in all samples investigated
in this study. It is important to note that not every single
exosome observed by TEM expressed this protein. Indeed,
the number of exosomes negative for CD63 was slightly
greater to the number of exosomes expressing the protein.
Discussion
Size and quantification
The commercial kit used states a simple and quick pre-
cipitation method for isolation of intact exosomes,
allowing them to be collected by a short, low-speed cen-
trifugation easily applicable in most clinical laboratories
[2]. The introduced NTA technology overcomes some
limitations inherent to TEM-based methods, such as
lack of absolute quantification and quick size determin-
ation of exosomes, as well as time-consuming protocols
for sample preparation. For that reason, NTA-based pro-
cedures appear highly suitable to rapidly characterize
size distribution and number of exosomes. However, the
NTA system is not able to distinguish between extracel-
lular vesicles (EVs) and other similar sized particles, such
as clusters of exosomes, cellular debris or protein aggre-
gates. Moreover, especially when working with precipita-
tion methods, co-isolation of non-exosomal particles, for
instance larger serum/plasma protein aggregates or lipo-
proteins, cannot be excluded [1, 17, 18]. These data
might explain why we were able to also observe minor
signals showing particles between 150 and 400 nm in
the size distribution graph (Fig. 1) in addition to the
major peak around 100 nm.
In our approach, culture-derived exosomes were found
to have a significantly larger average size than
serum-derived specimens, but an obvious size variation
between both types of cell cultures was not found. Dif-
ferent studies have provided evidence that EVs vary in
size depending on their cells of origin and there are even
data published showing variation based on the method
of visualization [19–21].
The exosome quantification variability between both
cell culture types under the same culture conditions
might be explained by the fact that C2 cells represent a
cancer cell line. Since exosome secretion is normally in-
creased in cancer [22], a higher exosome concentration
in C2 cell medium was expected. Compared to primary
FBs, the faster growth rate of C2 cells determines the
number of cells contained in each culture flask, an as-
pect that certainly influences the exosome production.
Moreover, it has been well documented that some types
of cancer cell lines shed higher amounts of exosomes
Table 2 Concentration and size distribution of exosomes
Sample ID Exosome concentration (xE10/mL) Particle size mean (nm) Type of sample
C248 17.5 +/− 0.9 120.9 +/− 2.1 C2 cells culture medium, 48 h incubation
C272 12.8 +/− 1.7 118.0 +/− 4.5 C2 cells culture medium, 72 h incubation
FB48 6.4 +/− 0.7 110.3 +/− 5.0 Primary FBs culture medium, 48 h incubation
FB72 7.3 +/− 1.5 129.0 +/− 7.4 Primary FBs culture medium, 72 h incubation
Culture medium-derived exosomes from C2 cell line and primary fibroblasts, after 48 and 72 h of incubation under exosome-free media conditions (mean +/−
standard error)
Table 3 Negative controls
Sample ID Exosome concentration (xE7/mL) Particle size mean (nm) Type of sample
CN1 0.88 +/− 0.36 188.2 +/− 62.1 PBS
CN2 1.33 +/− 0.75 138.9 +/− 69.6 RPMI 1640
CN3 1.40 +/− 0.34 130.4 +/− 11.5 RPMI 1640 + Exosome isolation kit
CN4 1.26 +/− 0.61 147.6 +/− 22.6 Complete culture medium + Exosome isolation kit
Solutions employed during harvest and dilution processing of exosomes (mean +/− standard error)
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than others and conditions like hypoxia may increase
exosome production up to 90% [23, 24]. Many other ele-
ments can also affect exosome shedding in normal and
diseased cells, including chemical factors like, calcium,
calcium ionophores, phosphatidylinositol 3-kinase, and
pH, as well as physical factors such as heat, ischemia,
cellular stresses, and loss of cellular attachment [25].
Compared to serum samples, the number of exosomes
found in cell culture media was significantly lower. It is
known that in vivo exosomes are shed by all types of
cells, in normal and diseased conditions [1, 2]. Taking
that into consideration, along with the intercellular
cross-talks occurring in complex organisms, the total
number of cells in a living organism (a dog in this case)
releasing exosomes into all body-fluid compartments, is
in fact not comparable to the limited number of cells
(2–3 × 106) contained in our in vitro culture system.
It is worth to mention that although an aim of this re-
port was to isolate and identify exosomes from different
dog serum samples, no differences in size distribution and
quantification between non-cancer and cancer dog pa-
tients were noticed. Hence, further investigations explor-
ing potential variations between healthy and diseased
groups including a larger number of individuals shall
follow, since some reports have already shown that cancer
cells secrete more exosomes than non-cancer cells [22].
Morphology and protein expression
Electron microscopy allowed the assessment of morph-
ology and protein expression. Since most optical
methods using light scattering to analyse substances or
matter, such as flow cytometry and optical microscopy,
are hardly able to detect particles smaller than 200 nm,
TEM is essential to study the morphology of exosomes
and is considered the standard method in this regard
[15, 26]. When referring to morphology of nanoparticles,
it involves their overall shape, while TEM detects also
ultrastructural differences in their shape, contrast and
surface patterns [3]. Although we and other researchers
described the morphology of exosomes as cup shaped
when observed by TEM, it seems to be an artefact gen-
erated by fixation and/or contrasting steps [13, 15], that
is also associated with shrinking of vesicles [27, 28].
Studies employing scanner electron microscopy and
cryo-electron microscopy revealed that exosomes have
indeed a round/spherical shape [15, 20, 29, 30].
Immunoelectron microscopy allowed the detection
and direct imaging of the transmembrane protein CD63,
Fig. 2 Transmission electron microscopy of native exosomes isolated from samples of canine origin. a blood serum-derived exosomes, b C2 cell
line culture-derived exosomes and (c and d) primary fibroblasts culture-derived exosomes. Size bar = 100 nm
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which bound to a selective secondary antibody labelled
with gold particles [31] (Fig. 3). Exosomes represent a
heterogeneous population of EVs expressing diverse pat-
terns of molecules. Numerous studies have shown that
some of these molecules are found frequently in exo-
somes, and therefore, they have gained support to be
used as exosomal markers, e.g. proteins [13, 15, 31].
Since they all bear an endosomal origin, it is expected
that exosomes contain different cargos of tetraspanin
proteins, a family of membrane proteins. The tetraspa-
nin CD63 is currently being used widely as a molecular
exosome marker by diverse research studies in this field
[7, 10]. The tetraspanin family includes a large amount
of transmembrane proteins and only the most common
members are made available as molecular exosomal
markers, including CD63, CD9, CD81 and CD82 [5, 7,
Fig. 3 Immunoelectron microscopy images of exosomes isolated from samples of canine origin. a and b serum-derived exosomes, c C2 cell line
culture-derived exosomes, d and e primary fibroblasts culture-derived exosomes. Note the gold particles bound to the exosome membrane
indicating presence of the tetraspanin CD63. Size bar = 100 nm
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10]. Several investigations have already demonstrated
that the molecular characteristics vary broadly among
exosomes from different sources, even across exosomes
secreted by the same type of cells [10, 22, 25]. Accord-
ingly, the fact that not all of the observed exosomes
expressed CD63 was indeed contemplated.
Conclusion
Our results evidence the feasibility to easily and rapidly
isolate intact exosomes from small volumes of serum, as
well as from a tumour cell line and a primary fibroblast
culture, all from dog origin, allowing nanoparticles to be
analysed in downstream applications. The NTA system
provides a quick and easy way to size and quantify exo-
somes, while TEM facilitates the morphology assessment
and distinct immunodetection. The exosome research
field has in the past years become an emerging area
among researchers of all biological sciences. However, in
veterinary medicine it is not yet a well-developed matter.
Hence, by demonstrating techniques of isolation,
characterization and exploration, this report supports
the data until now available in the veterinary diagnostic
field, encouraging scientists and clinicians to further ex-
plore exosomes of canine origin.
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